Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, and CAR-T cell therapy research.
Healthy lifestyle partly mediates the association between self-rated health and risk of overall and cause-specific mortality
Blockade of CCR5<sup>+</sup> T Cell Accumulation in the Tumor Microenvironment Optimizes Anti‐TGF‐β/PD‐L1 Bispecific Antibody
The correlation between KRAS and TP53 gene mutations and early growth of pulmonary nodules
Exploiting innate immunity for cancer immunotherapy
Effect of dietary patterns on dental caries among 12–15 years-old adolescents: a cross-sectional survey
Increased expression of ECT2 predicts the poor prognosis of breast cancer patients
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407
Tumor-Infiltrating Cytotoxic T Cells and Tumor-Associated Macrophages Correlate With the Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC
Fatal adverse events associated with programmed cell death protein 1 or programmed cell death-ligand 1 monotherapy in cancer
Randomized phase III study of first-line pembrolizumab plus pemetrexed/platinum followed by pembrolizumab and maintenance olaparib versus pemetrexed in patients with metastatic nonsquamous non-small cell lung cancer (NSCLC): KEYLYNK-006.
Risk of fatal adverse events in cancer patients treated with sunitinib
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
Incidence and Risk of Fatal Adverse Events in Cancer Patients Treated With Vascular Endothelial Growth Factor Receptor 2-Targeted Agents: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials
Corrigendum to “Incidence and clinical parameters associated with eribulin mesylate-induced peripheral neuropathy” [Crit. Rev. Oncol./Hematol. 128 (August) (2018) 110–117]
Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib
Correction: Incidence and risk of regorafenib-induced hepatotoxicity
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
Impact of clinicopathological characteristics on survival in patients treated with immune checkpoint inhibitors for metastatic melanoma
Impact of hormone receptor status on the efficacy of HER2-targeted treatment
Incidence and clinical parameters associated with eribulin mesylate-induced peripheral neuropathy
Beclin 1 and LC3 as predictive biomarkers for metastatic colorectal carcinoma
Incidence and risk of regorafenib-induced hepatotoxicity
Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor‐2‐positive breast cancer
Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib
Incidence and risk of eribulin mesylate related hematologic toxicity
Autophagy-based survival prognosis in human colorectal carcinoma
Interfacial Behavior of Stimuli-Responsive Multicomponent Molecular Bottlebrush Polymers
Collaborative Research: Directed Assembly of Nanoparticles and Polymers via Co-Crystallization
Shape Changing Stimuli-Responsive Multicomponent Molecular Bottlebrushes in Solution and at Interfaces
Collaborative Research: Polymer Single Crystal-Assisted "Grafting From": A Versatile Approach towards Multicomponent Polymer Brushes with Well-Defined Architectures and Grafting
Stimuli-Responsive Shape-Changing Molecular Brushes
Travel Support for an ACS PMSE Symposium Entitled "Hairy Particles: Theory, Synthesis, Behavior, and Applications", September 8-12, 2013, Indianapolis, IN
Tuning Aqueous Micellar Gels and Nanoparticle-Containing Hybrid Micellar Gels of Thermosensitive Hydrophilic Block Copolymers
Materials World Network: Collaborative Research: Nanoscale Self-Assembly of Well-Defined Binary Mixed Homopolymer Brushes Grafted on Inorganic Particles
Active Control of Sol-Gel-Sol Transitions of Aqueous Solutions of Doubly Responsive Hydrophilic Block Copolymers
Doubly Thermosensitive Block and Star Copolymers from Living Radical Polymerizations: Synthesis, Phase Transitions, and Applications